Donate
Australian & New Zealand Childrens Haematology/Oncology Group

ANZCHOG Children’s Cancer Clinical Trials Repository

Study Title
A combination Therapy Trial using an Adaptive Platform Design for Children and Young Adults with Diffuse Midline Gliomas (DMGs) including Diffuse Intrinsic Pontine Gliomas (DIPGS) at Initial Diagnosis, Post-Radiation Therapy and at Time of Progression
Protocol ID
PNOC022
Disease (Sub Disease)
Diffuse Midline Glioma
Diagnosis Stage
Newly diagnosed
Relapsed/Refractory
Location
NSW, VIC
Sponsor
Australian and New Zealand Children's Haematology Oncology Group
Collaborators
Pacific Pediatric Neuro-Oncology Consortium
Trial Status
Open
Sites
The Children's Hospital at Westmead
Royal Children's Hospital
Study Type
Treatment
Phase
Phase 1/2
Age Eligibility
2 Years to 39 Years
International registry ID's
NCT05009992
Back to Registry
Study Title A combination Therapy Trial using an Adaptive Platform Design for Children and Young Adults with Diffuse Midline Gliomas (DMGs) including Diffuse Intrinsic Pontine Gliomas (DIPGS) at Initial Diagnosis Post-Radiation Therapy and at Time of Progression
Protocol ID PNOC022
Disease (Sub Disease) Diffuse Midline Glioma
Diagnosis Stage Newly diagnosed
Relapsed/Refractory
Location NSW / VIC
Sponsor Australian and New Zealand Children's Haematology Oncology Group
Collaborators Pacific Pediatric Neuro-Oncology Consortium
Links https://clinicaltrials.gov/ct2/show/NCT05009992
Trial Status Open
Trial Open Date 18/08/2022
Sites The Children's Hospital at Westmead/ Royal Children's Hospital
Study Type Treatment
Phase Phase 1/2
Age Eligibility 2 Years to 39 Years
International registry ID's NCT05009992